Author

Minnie Gellamucho

Observed names: Gellamucho, Minnie, M Gellamucho, M. Gellamucho

Institutions: University College Hospital, University Hospitals of North Midlands NHS Trust, University College London

Observed institutions: University of Siena, University College Hospital, Roslin Institute, University Hospitals of North Midlands NHS Trust, Western General Hospital, Royal Stoke University Hospital, Glasgow Royal Infirmary, Edinburgh Royal Infirmary, King George Hospital, North Middlesex University Hospital NHS Trust, North Middlesex Hospital, Institute of Genetics and Cancer, MRC Human Genetics Unit, University College London, University of Edinburgh

OpenAlex ID: A5034486843

Mapping the human genetic architecture of COVID-19

2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 983

Whole-genome sequencing reveals host factors underlying critical COVID-19

2022 · Athanasios Kousathanas, Erola Pairo-Castineira, et al. · Nature · 326

PDF

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 224

PDF

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129

A second update on mapping the human genetic architecture of COVID-19

2023 · The COVID-19 Host Genetics Initiative, Leadership, et al. · Nature · 118

PDF

Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis

2024 · Paul Dark, Anower Hossain, et al. · JAMA · 110

PDF

INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia

2025 · Virve I. Enne, Susan Stirling, et al. · Intensive Care Medicine · 52

PDF

Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients

2025 · Daniel S. Martin, Doug W. Gould, et al. · JAMA · 48

PDF

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

PDF

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

PDF

Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

2021 · Chiara Fallerini, Nicola Picchiotti, et al. · Human Genetics · 37

PDF

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

PDF

Stratified analyses refine association between TLR7 rare variants and severe COVID-19

2024 · Jannik Boos, Caspar I. van der Made, et al. · Human Genetics and Genomics Advances · 12

PDF

Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT

2025 · Adam P. Wagner, Virve I. Enne, et al. · Critical Care · 9

PDF

Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

2023 · Erola Pairo-Castineira, Konrad Rawlik, et al. · Nature · 9

PDF

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

Mapping the human genetic architecture of COVID-19

2021 · Niemi, Mari E. K., Karjalainen, Juha, et al. · Research at the University of Copenhagen (University of Copenhagen) · 5

Correction: Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT

2025 · Adam P. Wagner, Virve I. Enne, et al. · Critical Care

PDF

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

PDF

Works count: 21

Citation count: 2,480

H-index: 12

I10-index: 14